Esomeprazole and Radiation Induced Esophagitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 30, 2027

Study Completion Date

June 30, 2028

Conditions
Radiation EsophagitisLocally Advanced Lung Carcinoma
Interventions
DRUG

Esomeprazole 40 mg

Enrolled patients will receive 40 mg of esomeprazole (two pills of 20 mg strength of esomeprazole) once daily before breakfast for the entire duration of TRT (including the weekends and any interim gap period) and for two weeks after completion of thoracic radiation therapy.

Trial Locations (1)

60612

RECRUITING

Rush University Medical Center, Chicago

All Listed Sponsors
lead

Rush University Medical Center

OTHER